SCHEMBL2570930

SCHEMBL2570930

O=Cn1cnc2ncccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
LTA4H P09960 1/20 0.35
RPS6KA5 O75582 3/20 0.35
KMT2A Q03164 2/20 0.34
POLB P06746 1/20 0.33
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
CYP2A6 P11509 1/20 0.33
DAO P14920 1/20 0.33
MKNK1 Q9BUB5 2/20 0.32
MKNK2 Q9HBH9 2/20 0.32
RPS6KA4 O75676 1/20 0.32
BACE1 P56817 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
HSP90AA1 P07900 1/20 0.32
IDO1 P14902 1/20 0.32
RAB9A P51151 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1165290 0.81 LTA4H (0.38) ALDH1A1LTA4HRPS6KA5KMT2APOLB
SCHEMBL7197967 0.75 LTA4H (0.33) LTA4HKMT2ABACE1NPC1RAB9A
SCHEMBL7149525 0.74 LTA4H (0.35) LTA4HKMT2AMKNK1MKNK2BACE1
SCHEMBL14198916 0.73 LTA4H (0.45) ALDH1A1LTA4HRPS6KA5KMT2AMKNK1
SCHEMBL222528 0.72 HTT (0.52) POLBFGFR1
SCHEMBL31229913 0.71 LTA4H (0.39) ALDH1A1LTA4HRPS6KA5KMT2APOLB
Hydrochloric Acid SCHEMBL28082087 0.71 HTT (0.50) POLBFGFR1
SCHEMBL13296647 0.69 LTA4H (0.38) ALDH1A1LTA4HRPS6KA5KMT2APOLB
SCHEMBL256361 0.69 LTA4H (0.41) ALDH1A1LTA4HRPS6KA5KMT2AMKNK1
SCHEMBL21295269 0.69 LTA4H (0.38) ALDH1A1LTA4HRPS6KA5KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786812-B1 PYRIDINE METHYLENE AZOLIDINONES AND THEIR USE AS PHOSPHOINOSITIDE INHIBITORS MERCK SERONO SA (CH) 2011-11-09 EP disclosed
US-7842698-B2 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors MERCK SERONO S.A. (CH) 2010-11-30 US disclosed
US-20080269227-A1 Pyridine Methylene Azolidinones and Use Thereof Phosphoinositide Inhibitors APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269227-A1 Pyridine Methylene Azolidinones and Use Thereof Phosphoinositide Inhibitors PIK3CD, PIK3CA, PIK3CB ALDH1A1 1437/4885LTA4H 1391/4885RPS6KA5 828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.